Malignant Biliary Tract Neoplasm — Trials

Malignant Biliary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,282 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 367
Recruiting: 209
Ph III recruiting: 19
Growth YoY: +15.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (152)

clinicaltrialsPublishedShowing 51–100 of 248 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05812430	Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer	unknown	Phase 2	20	The First Affiliated Hospital of Zhengzhou UniversityOTHER	1	Sep 13, 2023	clinicaltrials
NCT05681949	Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards(ADBoard)	unknown	N/A	1,200	Charite University, Berlin, GermanyOTHER	1